Soros Fund Management’s Medicines Co MDCO Stock Holding History

Soros Fund Management’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-21,000	Closed	-$1.78M	–	207
2019 Q4	$1.78M	Buy	+21,000	New	+$1.4M	0.06%	149
2014 Q3	–	Sell	-75,000	Closed	-$2.18M	–	390
2014 Q2	$2.18M	Buy	+75,000	New	+$2M	0.02%	241
2014 Q1	–	Sell	-50,000	Closed	-$1.93M	–	379
2013 Q4	$1.93M	Sell	50,000 -200,000	-80%	-$7.15M	0.02%	211
2013 Q3	$8.38M	Buy	250,000 +100,000	+67%	+$3.19M	0.09%	138
2013 Q2	$4.61M	Buy	+150,000	New	+$5.02M	0.05%	156

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Soros Fund Management's MDCO Position: Q1 2020 in Review

Soros Fund Management sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 21,000 shares — an estimated $1.78M sold.

Soros Fund Management first reported a position in MDCO in Q2 2013 and held it in 5 quarters. The position peaked at $8.38M in Q3 2013. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

Soros Fund Management reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
Soros Fund Management sold 21,000 Medicines Co shares in Q1 2020, an estimated $1.78M.
Soros Fund Management first reported a position in Medicines Co in Q2 2013 and held it in 5 quarters.
Soros Fund Management's Medicines Co position peaked at $8.38M in Q3 2013.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Soros Fund Management's 13F filing for Q1 2020, filed 15 May 2020.